I bought the shares the very first time today. Having followed...

I bought the shares the very first time today. Having followed the company ( not too closely) since it's inception , I thought this news is great.
I wasn't a fan of 4DX as I didn't think it's a common medical procedure with the original application - fluoroscopy. You find such service only in hospitals with limited use in lung scanning. Overall, fluoroscopy has become almost obsolete nowadays.

I must have missed the announcement that 4DX has developed CT LVAS. Unlike fluoroscopy unit, every hospital and private radiology practice has a CT scanner. And lung scanning is the bread and butter type of CT procedure. It's the most common type of CT study for new symptom, follow up study, with an age group ranging from young to old. With 4DX software, additional information can be obtained at no extra cost or radiation penalty.

Even better now, it has gained CMS reimbursement. This company can be huge potentially. Hopefully we can see big uptick in revenue in the next 4c or at least by the end of the year.